Unknown

Dataset Information

0

Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.


ABSTRACT: BACKGROUND:Intratumor subsets with tumor-initiating features in glioblastoma are likely to survive treatment. Our goal is to identify the key factor in the process by which cells develop temozolomide (TMZ) resistance. METHODS:Resistant cell lines derived from U87MG and A172 were established through long-term co-incubation of TMZ. Primary tumors obtained from patients were maintained as patient-derived xenograft for studies of tumor-initating cell (TIC) features. The cell manifestations were assessed in the gene modulated cells for relevance to drug resistance. RESULTS:Among the mitochondria-related genes in the gene expression databases, superoxide dismutase 2 (SOD2) was a significant factor in resistance and patient survival. SOD2 in the resistant cells functionally determined the cell fate by limiting TMZ-stimulated superoxide reaction and cleavage of caspase-3. Genetic inhibition of the protein led to retrieval of drug effect in mouse study. SOD2 was also associated with the TIC features, which enriched in the resistant cells. The CD133+ specific subsets in the resistant cells exhibited superior superoxide regulation and the SOD2-related caspase-3 reaction. Experiments applying SOD2 modulation showed a positive correlation between the TIC features and the protein expression. Finally, co-treatment with TMZ and the SOD inhibitor sodium diethyldithiocarbamate trihydrate in xenograft mouse models with the TMZ-resistant primary tumor resulted in lower tumor proliferation, longer survival, and less CD133, Bmi-1, and SOD2 expression. CONCLUSION:SOD2 plays crucial roles in the tumor-initiating features that are related to TMZ resistance. Inhibition of the protein is a potential therapeutic strategy that can be used to enhance the effects of chemotherapy.

SUBMITTER: Chien CH 

PROVIDER: S-EPMC6800988 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.

Chien Chia-Hung CH   Chuang Jian-Ying JY   Yang Shun-Tai ST   Yang Wen-Bin WB   Chen Pin-Yuan PY   Hsu Tsung-I TI   Huang Chih-Yuan CY   Lo Wei-Lun WL   Yang Ka-Yen KY   Liu Ming-Sheng MS   Chu Jui-Mei JM   Chung Pei-Hsuan PH   Liu Jr-Jiun JJ   Chou Shao-Wen SW   Chen Shang-Hung SH   Chang Kwang-Yu KY  

Journal of biomedical science 20191019 1


<h4>Background</h4>Intratumor subsets with tumor-initiating features in glioblastoma are likely to survive treatment. Our goal is to identify the key factor in the process by which cells develop temozolomide (TMZ) resistance.<h4>Methods</h4>Resistant cell lines derived from U87MG and A172 were established through long-term co-incubation of TMZ. Primary tumors obtained from patients were maintained as patient-derived xenograft for studies of tumor-initating cell (TIC) features. The cell manifesta  ...[more]

Similar Datasets

| S-EPMC6944699 | biostudies-literature
| S-EPMC10178422 | biostudies-literature
| S-EPMC3926825 | biostudies-other
| S-EPMC6237285 | biostudies-literature
| S-EPMC4199660 | biostudies-literature
| S-EPMC3734828 | biostudies-literature
| S-EPMC8952270 | biostudies-literature
| S-EPMC9377222 | biostudies-literature
| S-EPMC5346677 | biostudies-literature